Bran Behandlung von Prostatitis

Chronic Prostatitis (Prostate Inflammation) - Causes, Treatment & Symptoms

Sowohl zu Hause Heilung Vesikulitis

Chronic bacterial prostatitis is a rare infection but difficult to treat. Usually co-trimoxazole has been used, yet with poor results. Because of their favorable pharmacokinetics and their broad antibacterial spectrum, the newer quinolones may be a good alternative. For prostatic fluid measurements, however, possible urinary contamination bran Behandlung von Prostatitis to be considered and identified otherwise falsely high levels are measured.

A total of 23 studies with the newer quinolones norfloxacin, ciprofloxacin, ofloxacin, pefloxacin, enoxacin, temafloxacin and rufloxacin in the treatment of chronic bacterial prostatitis are available.

However, the results of these studies are difficult to compare because not all investigators used the same diagnostic criteria and there was a considerable range of duration of treatment and of follow-up. Since the issue involved in the treatment of prostatitis is that of relapse, patients cannot be considered cured if they have been followed for one week or one month only.

There were four studies bran Behandlung von Prostatitis the 23 publications, i. The results are promising, but further investigations, especially controlled studies, are needed in order to determine the role of the newer quinolones in the treatment of chronic bacterial prostatitis. Die chronisch bakterielle Prostatitis ist eine seltene, bran Behandlung von Prostatitis schwer zu behandelnde Infektion.

Gewöhnlich wurde Co-trimoxazol verwendet, wenn auch mit schlechten Therapieergebnissen. Wegen der günstigen pharmakokinetischen Eigenschaften und des breiten antibakteriellen Spektrums könnten die neureren Chinolone eine gute Alternative sein. Bei der Bestimmung der Prostatasekretkonzentrationen müssen jedoch Urinkontaminationen sorgfältig ausgeschlossen werden, um nicht fälschlich hohe Konzentrationen zu erhalten.

Insgesamt wurden 23 Studien analysiert, in denen neuere Chinolone Norfloxacin, Ciprofloxacin, Ofloxacin, Pefloxacin, Enoxacin, Temafloxacin und Rufloxacin zur Therapie der chronisch bakteriellen Prostatitis verwendet bran Behandlung von Prostatitis. Die Ergebnisse sind jedoch schwer vergleichbar, da nicht alle Autoren dieselben diagnostischen Kriterien verwendeten und es auch eine erhebliche Schwankungsbreite in der Therapiedauer und Nachbeobachtungszeit gab.

Die Ergebnisse sind ermutigend, aber weitere Untersuchungen, insbesondere kontrollierte Studien, sind erforderlich, um die Rolle bran Behandlung von Prostatitis neueren Chinolone bei der Behandlung der chronisch bakteriellen Prostatitis bestimmen zu können. Skip to main content. Advertisement Hide. The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors Authors and affiliations K. This process is experimental and the keywords may be updated as the learning algorithm improves.

Die Rolle der Chinolone bei der Behandlung der chronisch bakteriellen Prostatitis. This is a preview of subscription content, log in to check access.

Meares, E. Prostatitis syndromes: new perspectives about old woes. Google Scholar. Stamey, T. Chronic bacterial prostatitis and bran Behandlung von Prostatitis diffusion of drugs into prostatic bran Behandlung von Prostatitis.

Bacteriologic localization patterns in bacterial prostatitis and urethritis. Urology 5 — Hanus, P. Treatment of chronic bacterial prostatitis. Clinical Pharmacy 3 49— Smith, J. Recurrent bran Behandlung von Prostatitis tract infections in men. Serum antibody titers in treatment with trimethoprim-sulfamethoxazole for chronic prostatitis. Urology 11 — Observations on activity of trimethoprim-sulfamethoxazole in the prostate. Drach, G. Trimethoprim-sulfamethoxazole therapy of chronic bacterial prostatitis.

Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole. Bran Behandlung von Prostatitis, E. Bacterial prostatitis. Treatment with trimethoprim-sulfamethoxazole. Urology 7 — Paulson, D. Trimethoprim-sulfamethoxazole and minocyclinehydrochloride in the treatment of culture-proved bacterial prostatitis.

Pfau, A. Prostatitis: A continuing enigma. North Am. Mobley, D. Bran Behandlung von Prostatitis plus sodium bicarbonate in chronic bacterial prostatitis. Urology 3 60— Oliveri, R. Clinical experiences with geocillin in the treatment of bacterial prostatitis. Current Therapeutic Research 25 — Bacterial prostatitis: Treatment with carbenicillin indanyl sodium.

Sabath, L. Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. Zinner, S. Erythromycin and alkalinization of the urine in the treatment of urinary tract infections due to gram-negative bacilli. Lancet i — The pH of the prostatic fluid in health and disease: Implications of treatment in chronic bacterial prostatitis. Anderson, R. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis and adenocarcinoma.

Blacklock, N. The response of fluid pH in inflammation. A review. Madsen, P. O :, Baumueller, A. Experimental models for determination of antimicrobials in prostatic tissue, interstitital fluid and secretion. The concentration of various quinolone derivatives in the dog prostate. In: Weidner, W. Zuckschwerdt, Munichpp. Gasser, T. Fleroxacin Ro distribution in canine bran Behandlung von Prostatitis tissue and fluids. Naber, K.

Ecomed,pp. Enoxacin-Konzentrationen bran Behandlung von Prostatitis der Samenflüssigkeit, im Prostatasekret und im Prostataadenomgewebe nach oraler Gabe oder intravenöser Infusion.

Infection 17 Suppl. In vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and bran Behandlung von Prostatitis fluid and in prostatic adenoma tissue. D — Pharmakokinetik von Ciprofloxacin bei Probanden und älteren Patienten und Konzentrationen im Prostatasekret, Ejakulat und im Prostataadenomgewebe nach intravenöser Gabe.

FAC Futuramed, Munichpp. Brief report: Pharmacokinetics of ciprofloxacin in young healthy volunteers and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic aedenoma tissue following intravenous administration. New Quinolones, VancouverAbstract No. Dalhoff, A. Diffusion of ciprofloxacin into prostatic fluid.

Boerema, J. Ciprofloxacin distribution in protatic tissue and fluid following oral administration. Chemotherapy 31 13— Kumon, H. The concentration of ofloxacin in human prostatic tissue and fluid. In: Ishigami, J. Recent advances in chemotherapy. Section 2. University of Tokyo Press, Tokyopp. Suzuki, K.